Predict your next investment

HEALTHCARE | Drug Development
brickellbio.com

See what CB Insights has to offer

Founded Year

2009

Stage

IPO | IPO

Total Raised

$26.09M

Date of IPO

6/17/2020

Market Cap

0.04B

Stock Price

0.32

About Brickell Biotech

Brickell Biotech is a clinical-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of skin diseases. Brickell's development strategy includes: rapidly and cost-effectively developing product candidates, executing strategic partnerships, maintaining a diversified product portfolio that addresses unmet medical needs, and leveraging professional relationships with professionals and contract research organizations in the pharmaceutical industry.

Brickell Biotech Headquarter Location

5777 Central Avenue Suite 102

Boulder, Colorado, 80301,

United States

720-505-4755

Latest Brickell Biotech News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Brickell Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Brickell Biotech is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Brickell Biotech Patents

Brickell Biotech has filed 6 patents.

The 3 most popular patent topics include:

  • H1 receptor antagonists
  • Muscarinic antagonists
  • Piperidines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/5/2011

6/27/2017

Immunology, Autoimmune diseases, Prostaglandins, Inflammations, Eicosanoids

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/5/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/27/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Immunology, Autoimmune diseases, Prostaglandins, Inflammations, Eicosanoids

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Brickell Biotech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Brickell Biotech Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.